Regeneron’s Prostate Cancer Combo Candidate Shows Encouraging Anti-Tumor Activity
Regeneron Pharmaceuticals Inc (NASDAQ:REGN) earned $9.77 per share for Q2 FY22, down 62% Y/Y, beating the $9.54 estimate. Sales decreased…
BorgWarner Shares Gain On Q2 Results, Acquires Rhombus Energy Solutions
BorgWarner Inc (NYSE:BWA) reported second-quarter FY22 sales, flat year-on-year at $3.76 billion, beating the consensus of $3.70 billion. Nets sales…
Merrimack Pharma-Ipsen’s Cancer Drug Fails In Overall Survival Measure
Merrimack Pharmaceuticals Inc’s (NASDAQ:MACK) partner announced that Ipsen SA (OTC:IPSEY) reported a primary analysis of the results of the…
PayPal Analysts Increase Price Targets Following Earnings Report, Elliott Management’s $2B Investment
Analysts are diving into the second quarter earnings report from PayPal Holdings (NASDAQ: PYPL) and evaluating what a $2 billion stake from Elliott Management could mean for the financial technology company's future.
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
Horizon Therapeutics’ Shares Tumble On Q2 Miss, Trimmed FY22 Outlook
Horizon Therapeutics plc’s (NASDAQ:HZNP) reported Q2 sales of $876.4 million, +5% Y/Y, missing the consensus of $936.10 million. The adjusted…
This Favorable Sign Appears On American Tower’s Chart
If history is any guide, there may be good fortune ahead for shares of American Tower (NYSE:AMT). A so-called "golden cross" has formed on its chart and, not surprisingly, this could be bullish for the stock.
Why Upstart And Other Lending Stocks Are Catching Bids Today
Upstart Holdings Inc (NASDAQ: UPST) shares are trading higher Wednesday, in sympathy with SoFi Technologies Inc (NASDAQ: SOFI), which reported better-than-expected financial results and raised full-y
Owens & Minor Shares Slip On FY22 Outlook Cut
Owens & Minor Inc (NYSE:OMI) reported second-quarter revenue of $2.50 billion, an increase of 0.44% year-over-year, missing the consensus of…
Cryptocurrency VeChain Up More Than 9% In 24 hours
Over the past 24 hours, VeChain's (CRYPTO: VET) price rose 9.59% to $0.03. This continues its positive trend over the past week where it has experienced a 25.0% gain, moving from $0.02 to its current price. As it stands right now, the coin's all-time high is $0.28.